Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 18/20 | 1.00 |
| ▸ | ITGA2B | P08514 | 18/20 | 1.00 |
| ▸ | ITGB2 | P05107 | 2/20 | 1.00 |
| ▸ | ITGAM | P11215 | 2/20 | 1.00 |
| ▸ | F2 | P00734 | 2/20 | 0.70 |
| ▸ | F10 | P00742 | 2/20 | 0.70 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21705670 | 0.89 | ITGB3 (0.80) | ITGB3ITGA2BITGB2ITGAMF2 | |
| SCHEMBL12556242 | 0.85 | ITGB3 (0.74) | ITGB3ITGA2BITGB2ITGAM | |
| SCHEMBL7090791 | 0.83 | ITGB3 (0.89) | ITGB3ITGA2BITGB2ITGAMF2 | |
| SCHEMBL12517811 | 0.83 | ITGB3 (0.70) | ITGB3ITGA2BITGB2ITGAMF2 | |
| SCHEMBL7373045 | 0.79 | MIF (0.72) | ITGB3ITGA2BITGB2ITGAMF2 | |
| SCHEMBL7372374 | 0.79 | MIF (0.72) | ITGB3ITGA2BITGB2ITGAMF2 | |
| SCHEMBL21706030 | 0.77 | ITGB3 (0.75) | ITGB3ITGA2BITGB2ITGAM | |
| SCHEMBL21706057 | 0.77 | ITGB3 (0.66) | ITGB3ITGA2BITGB2ITGAMF2 | |
| SCHEMBL21706040 | 0.75 | F2 (0.64) | ITGB3ITGA2BITGB2ITGAMF2 | |
| SCHEMBL12556240 | 0.74 | MIF (0.74) | ITGB3ITGA2BITGB2ITGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995014682-A1 | ISOXAZOLINE COMPOUNDS USEFUL AS FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-06-01 | — | — | WO | disclosed |